Lalithaa Jewellery IPO Debuts 32% Higher; Symbiotec Opens

Lalithaa Jewellery Mart shares listed at a 32% premium over its IPO price of Rs 201 on August 24, 2026, opening at Rs 265 on the NSE. The Chennai-based retailer’s Rs 1,700 crore IPO had previously seen significant investor demand.

Lalithaa Shines on Debut

This strong debut, however, was slightly below the grey market’s indicated 37% gain. The IPO was heavily oversubscribed, reflecting investor appetite for consumption stories.

• IPO Price: Rs 201
• Opening Price (NSE): Rs 265
• Opening Price (BSE): Rs 265.30
• Oversubscription: 62.97 times overall

Symbiotec’s Volatile GMP

Symbiotec Pharmalab, an Indore-based API and CDMO manufacturer, opened its Rs 1,757 crore IPO for subscription. The price band was set between Rs 938 and Rs 988 per share.

Its grey market premium (GMP) showed considerable volatility, swinging between 22% and 41% over the past week. The company plans to use Rs 112.5 crore from the fresh issue for partial debt repayment.

Horizon’s Flat Listing

Horizon Industrial Parks, India’s largest industrial and logistics infrastructure platform, experienced a muted market debut. The company is 89% owned by Blackstone affiliates.

It listed almost flat, opening at Rs 60.25 on the NSE and slipping to Rs 59.65 on the BSE against its Rs 60 issue price. The Rs 2,600 crore IPO was subscribed only 1.45 times.

• IPO Subscription: 1.45 times
• Planned Debt Repayment: Rs 2,250 crore
• Total Debt: Rs 6,884.34 crore

Investor Sentiment Diverges

These IPO outcomes offer a case study on current investor sentiment in India’s primary market. Consumption-focused businesses like Lalithaa are seeing high demand.

Specialty manufacturing firms like Symbiotec attract interest, but at full valuations. Debt-heavy infrastructure plays such as Horizon are being priced cautiously, even with institutional backing.